SSTR2A is a diagnostic marker of trichogerminoma

Mélanie Legrand¹, Daniel Pissaloux^{2

3}, Franck Tirode^{2

3}, Anne Tallet⁴, Christine Collin⁴, Paul-Louis Chantreau¹, Patricia Berthon⁵, Marie-Laure Jullie^{6

7}, Pierre Sohier^{6

8}, Eduardo Calonje⁹, Boštjan Luzar¹⁰, Isabelle Moulonguet¹¹, Keisuke Goto^{12

13

14

15}, Kristof Cokelaere¹⁶, Laurence Lamant¹⁷, Brigitte Balme¹⁸, Lydia Deschamps¹⁹, Nicolas Macagno^{6

20}, Bernard Cribier^{6

21}, Maxime Battistella^{6

11}, Arnaud de la Fouchardière^{2

3}, Thibault Kervarrec^{1

5

6}

Affiliations

¹ Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
² Department of Biopathology, Center Léon Bérard, Lyon, France.
³ Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
⁴ Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
⁵ "Biologie des infections à polyomavirus" team, UMR INRA ISP 1282, Université de Tours, Tours, France.
⁶ French Network of Rare Skin Cancers, CARADERM, France.
⁷ Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France, CARADERM network.
⁸ Department of Pathology, Hôpital Cochin, AP-HP, AP-HP.Centre - Faculté de Médecine, University Paris Cité, Paris, France.
⁹ Department of Dermatopathology, St John's Institute of Dermatology, St Thomas's Hospital, London, UK.
¹⁰ Institute of Pathology, Medical Faculty University of Ljubljana, Ljubljana, Slovenia.
¹¹ Department of Pathology, APHP Hôpital Saint Louis, Université Paris Cité, Paris, France.
¹² Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
¹³ Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Japan.
¹⁴ Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
¹⁵ Department of Dermatology, Hyogo Cancer Center, Akashi, Japan.
¹⁶ Department of Pathology, Jan Yperman Hospital, Belgium.
¹⁷ Department of Pathology, CHU Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France.
¹⁸ Department of Pathology, Centre Hospitalier Universitaire de Lyon, Lyon, France.
¹⁹ Department of Pathology, APHP Bichat Hospital, Paris, France.
²⁰ Department of Pathology, Timone University Hospital, Marseille, France.
²¹ Dermatology Clinic, Hôpitaux Universitaires & Université de Strasbourg, Hôpital Civil, Strasbourg, France.

PMID: 37421254
DOI: 10.1111/jdv.19319

SSTR2A is a diagnostic marker of trichogerminoma

Mélanie Legrand et al. J Eur Acad Dermatol Venereol. 2023 Nov.

. 2023 Nov;37(11):e1344-e1347.

doi: 10.1111/jdv.19319. Epub 2023 Jul 11.

Authors

Affiliations

¹ Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
² Department of Biopathology, Center Léon Bérard, Lyon, France.
³ Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
⁴ Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
⁵ "Biologie des infections à polyomavirus" team, UMR INRA ISP 1282, Université de Tours, Tours, France.
⁶ French Network of Rare Skin Cancers, CARADERM, France.
⁷ Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France, CARADERM network.
⁸ Department of Pathology, Hôpital Cochin, AP-HP, AP-HP.Centre - Faculté de Médecine, University Paris Cité, Paris, France.
⁹ Department of Dermatopathology, St John's Institute of Dermatology, St Thomas's Hospital, London, UK.
¹⁰ Institute of Pathology, Medical Faculty University of Ljubljana, Ljubljana, Slovenia.
¹¹ Department of Pathology, APHP Hôpital Saint Louis, Université Paris Cité, Paris, France.
¹² Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
¹³ Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Japan.
¹⁴ Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
¹⁵ Department of Dermatology, Hyogo Cancer Center, Akashi, Japan.
¹⁶ Department of Pathology, Jan Yperman Hospital, Belgium.
¹⁷ Department of Pathology, CHU Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France.
¹⁸ Department of Pathology, Centre Hospitalier Universitaire de Lyon, Lyon, France.
¹⁹ Department of Pathology, APHP Bichat Hospital, Paris, France.
²⁰ Department of Pathology, Timone University Hospital, Marseille, France.
²¹ Dermatology Clinic, Hôpitaux Universitaires & Université de Strasbourg, Hôpital Civil, Strasbourg, France.

PMID: 37421254
DOI: 10.1111/jdv.19319

No abstract available

PubMed Disclaimer

References

REFERENCES

1. Sau P, Lupton GP, Graham JH. Trichogerminoma. Report of 14 cases. J Cutan Pathol. 1992;19:357-365.
1. Kervarrec T, Pissaloux D, Poilane J, Tirode F, Tallet A, Collin C, et al. Recurrent FOXK1::GRHL and GPS2::GRHL fusions in trichogerminoma. J Pathol. 2022;257:96-108.
1. Macagno N, Pissaloux D, de la Fouchardière A, Karanian M, Lantuejoul S, Galateau Salle F, et al. Wholistic approach: transcriptomic analysis and beyond using archival material for molecular diagnosis. Genes Chromosom Cancer. 2022;61:382-393.
1. Volante M, Brizzi MP, Faggiano A, Rosa SL, Rapa I, Ferrero A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol. 2007;20:1172-1182.
1. Thanguturi S, Tallet A, Miquelestorena-Standley E, Coco C, le Corre Y, Hainaut-Wierzbicka E, et al. Investigation of the RB1-SOX2 axis constitutes a tool for viral status determination and diagnosis in Merkel cell carcinoma. Virchows Arch. 2022;480:1239-1254.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SSTR2A is a diagnostic marker of trichogerminoma

Affiliations

SSTR2A is a diagnostic marker of trichogerminoma

Authors

Affiliations

References

REFERENCES

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources